Real-world discontinuation rates of ocrelizumab are low, similar to pivotal trials, with rates between 3.2% and 4.1% for RRMS and PPMS. Side effects are the most common reason for discontinuation ...

Subcutaneous ocrelizumab (SC OCR) maintains a safety profile similar to intravenous administration in multiple sclerosis patients. A 920 mg SC OCR dose was identified as optimal, with mild to ...

Pets cherished during the lonely days of the pandemic are now being abandoned and Hong Kong care groups are struggling to cope.

With the acute phase of the Covid-19 pandemic fading even as the coronavirus persists and evolves, a new normal is taking shape around the world. Experts expect cases to rise again this winter.

It’s been five years since the COVID-19 pandemic began—and a lot has changed. From early in the pandemic until now, COVID went from causing fear, death, shortages, and uncertainty to being regarded by ...

Here’s the latest on symptoms, treatments and testing. By Dani Blum Dani Blum has reported on Covid since the spring of 2020. There are few constants when it comes to Covid, but one thing has ...

Who’s at the peak? COVID-19 has hit some countries far harder than others, though differences in the way infections are counted locally make it impossible to make a perfect apples-to-apples ...

Japanese version The data on this "Coronavirus (COVID-19) infections in Japan" page is based on original coverage by the Mainichi Shimbun and press releases from the Ministry of Health ...

Cases of whooping cough have exploded to the highest rate in more than a decade with young children affected the most by the deadly infection.

Roche has reported a 7% increase in full-year 2024 sales at constant exchange rates (CER), reaching CHF 60.5bn ($66.9bn). The ...

Those plans could also be under threat however, as BMS has said it will delay clinical trials due to the COVID-19 pandemic ... Roche’s fast-growing Ocrevus (ocrelizumab) infusion – which ...

© 2024 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and ...